Big Gain For Evoke Pharma, Inc.

Tue, Apr 26, 2022 at 05:30 PM

Evoke Pharma, Inc. (EVOK:NASDAQ) jumped higher at $0.86, a gain of 118.5%. On Mon, Apr 25, 2022, EVOK:NASDAQ hit a New 2-Week Intraday Low of $0.36. The stock got featured on our News Catalysts scanner on Tue, Apr 26, 2022 at 01:11 PM in the 'BIOTECH' category. From Mon, Apr 11, 2022, the stock recorded 33.33% Up Days and 20.00% Green Days

About Evoke Pharma, Inc. (EVOK:NASDAQ)

Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.

Top 10 Gainers:

Evoke Pharma, Inc. (EVOK:NASDAQ), 118.5%
Nutex Health Inc. (NUTX:NASDAQ), 73.76%
Cyngn Inc. (CYN:NASDAQ), 52.07%
Forge Global Holdings Inc. (FRGE:NYSE), 40.38%
Jiuzi Holdings Inc. (JZXN:NASDAQ), 27.27%
Avadel Pharmaceuticals plc (AVDL:NASDAQ), 25.89%
Addex Therapeutics Ltd (ADXN:NASDAQ), 23.84%
Arch Coal, Inc. (ARCH:NYSE), 20.95%
Lizhi Inc. (LIZI:NASDAQ), 20%
Q&K International Group Limited (QK:NASDAQ), 18.57%